Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
UROMITEXAN BAXTER CORPORATION Actual shortage 100MG Updated Report 2024-05-25 228511
THALOMID BRISTOL-MYERS SQUIBB CANADA Actual shortage 50MG Updated Report 2024-05-25 228619
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Resolved 16MG 12.5MG Updated Report 2024-05-25 211765
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Resolved 12.5MG 32MG Updated Report 2024-05-25 211768
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Resolved 12.5MG 32MG Updated Report 2024-05-25 211771
JAMP CANDESARTAN-HCT JAMP PHARMA CORPORATION Resolved 12.5MG 16MG Updated Report 2024-05-25 218700
MYLAN-VARDENAFIL MYLAN PHARMACEUTICALS ULC Actual shortage 20MG Updated Report 2024-05-25 228378
METHOTREXATE SUBCUTANEOUS ACCORD HEALTHCARE INC Actual shortage 25MG Updated Report 2024-05-25 228605
JAMP DIGOXIN JAMP PHARMA CORPORATION Actual shortage 0.0625MG Updated Report 2024-05-25 228715
COSOPT PRESERVATIVE-FREE ELVIUM LIFE SCIENCES Resolved 5MG 20MG Updated Report 2024-05-25 227864

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
REPATHA AMGEN CANADA INC To be discontinued 120MG Updated Report 2024-05-24 223420
ZOVIRAX GLAXOSMITHKLINE INC Discontinued 200MG New Report 2024-05-24 228728
VITAMIN A ACID BAUSCH HEALTH, CANADA INC. Discontinued 0.01% Updated Report 2024-05-23 217835
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) SANDOZ CANADA INCORPORATED Discontinued 10000UNIT Updated Report 2024-05-18 228249
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 20MG Updated Report 2024-05-18 228256